Loading chat...
DE SB137
Bill
Status
9/14/2011
Primary Sponsor
D.E. Williams
Click for details
AI Summary
-
Directs the Delaware Healthcare Commission to conduct a study on specialty tier prescription drugs to assess their impact on access and patient care.
-
Requires the Commission to submit a report to the General Assembly summarizing the study findings by March 15, 2012.
-
Addresses concerns about specialty tier drugs (fourth tier or higher) used to treat conditions such as hemophilia, HIV, hepatitis, multiple sclerosis, lupus, some cancers, and rheumatoid arthritis.
-
Distinguishes specialty tier cost-sharing from lower tiers by noting that specialty tiers require coinsurance percentages (20-30% or more) of drug costs rather than fixed copayments.
Legislative Description
An Act To Amend Title 18 Of The Delaware Code Relating To Cost-sharing, Deductible Or Co-insurance For Tier Iv Or Specialty Tier Prescription Drugs.
Last Action
Signed by Governor
9/14/2011